GR1006121B - Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down) - Google Patents

Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Info

Publication number
GR1006121B
GR1006121B GR20070100651A GR20070100651A GR1006121B GR 1006121 B GR1006121 B GR 1006121B GR 20070100651 A GR20070100651 A GR 20070100651A GR 20070100651 A GR20070100651 A GR 20070100651A GR 1006121 B GR1006121 B GR 1006121B
Authority
GR
Greece
Prior art keywords
protein
trisomy
samp
sap
component
Prior art date
Application number
GR20070100651A
Other languages
English (en)
Inventor
-
Original Assignee
��������������� ������� ��������� ������ (40%)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������������� ������� ��������� ������ (40%), filed Critical ��������������� ������� ��������� ������ (40%)
Priority to GR20070100651A priority Critical patent/GR1006121B/el
Priority to DE602008005228T priority patent/DE602008005228D1/de
Priority to SI200830247T priority patent/SI2053407T1/sl
Priority to PT08386023T priority patent/PT2053407E/pt
Priority to ES08386023T priority patent/ES2362051T3/es
Priority to AT08386023T priority patent/ATE500513T1/de
Priority to DK08386023.9T priority patent/DK2053407T3/da
Priority to PL08386023T priority patent/PL2053407T3/pl
Priority to EP08386023A priority patent/EP2053407B1/en
Publication of GR1006121B publication Critical patent/GR1006121B/el
Priority to HR20110371T priority patent/HRP20110371T1/hr
Priority to CY20111100524T priority patent/CY1112415T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

Η πρωτεΐνη serum amyloid P-component (SAP, SAMP) ως προγνωστικός και διαγνωστικός δείκτης για τον προγεννητικό έλεγχο της τρισωμίας 21 (σύνδρομο Down).
GR20070100651A 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down) GR1006121B (el)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GR20070100651A GR1006121B (el) 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)
AT08386023T ATE500513T1 (de) 2007-10-26 2008-10-13 Die proteinserum-amyloid p-komponente (sap, samp) als prognose- und diagnose-marker für die pränatale diagnose von trisomie 21 (down syndrom)
SI200830247T SI2053407T1 (sl) 2007-10-26 2008-10-13 Proteinska serumska amiloidna P-komponenta (SAP, SAMP) kot prognostični in diagnostični marker za prenatalno diagnozo trisomije 21 (Downovega sindroma)
PT08386023T PT2053407E (pt) 2007-10-26 2008-10-13 Componente da prote?na amil?ide p s?rica (sap, samp) como marcador de progn?stico e diagn?stico para o diagn?stico pr?-natal de trissomia 21 (s?ndrome de down)
ES08386023T ES2362051T3 (es) 2007-10-26 2008-10-13 La proteína componente de amiloide p de suero (sap, samp) como marcador de pronóstico y diagnóstico para el diagnóstico prenatal de la trisomía 21 (síndrome de down).
DE602008005228T DE602008005228D1 (de) 2007-10-26 2008-10-13 Die Proteinserum-Amyloid P-Komponente (SAP, SAMP) als Prognose- und Diagnose-Marker für die pränatale Diagnose von Trisomie 21 (Down Syndrom)
DK08386023.9T DK2053407T3 (da) 2007-10-26 2008-10-13 Proteinet serum amyloid P-komponent (SAP, SAMP) som prognose og diagnose markør til prænatal diagnose af Trisomi 21 (Downs syndrom)
PL08386023T PL2053407T3 (pl) 2007-10-26 2008-10-13 Składnik surowiczego białka amyloidu P (SAP, SAMP) jako marker prognostyczny i diagnostyczny w prenatalnym diagnozowaniu trisomii 21 (zespołu Downa)
EP08386023A EP2053407B1 (en) 2007-10-26 2008-10-13 The protein serum amyloid P-component (SAP, SAMP) as prognostic and diagnostic marker for the prenatal diagnosis of Trisomy 21 (Down syndrome)
HR20110371T HRP20110371T1 (hr) 2007-10-26 2011-05-19 Proteinski serum amiloidne komponente p (sap, samp, swissprot br. p02743) kao prognostički i dijagnostički marker za prenatalnu dijagnozu trisomije 21 (downovog sindroma)
CY20111100524T CY1112415T1 (el) 2007-10-26 2011-05-31 Η πρωτεϊνη serum amyloid p-component (sap, samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20070100651A GR1006121B (el) 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Publications (1)

Publication Number Publication Date
GR1006121B true GR1006121B (el) 2008-10-24

Family

ID=40030173

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20070100651A GR1006121B (el) 2007-10-26 2007-10-26 Η πρωτεϊνη serum amyloid p-component (sap,samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down)

Country Status (11)

Country Link
EP (1) EP2053407B1 (el)
AT (1) ATE500513T1 (el)
CY (1) CY1112415T1 (el)
DE (1) DE602008005228D1 (el)
DK (1) DK2053407T3 (el)
ES (1) ES2362051T3 (el)
GR (1) GR1006121B (el)
HR (1) HRP20110371T1 (el)
PL (1) PL2053407T3 (el)
PT (1) PT2053407E (el)
SI (1) SI2053407T1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104849471A (zh) * 2015-04-22 2015-08-19 戴勇 唐氏综合征图谱模型的构建方法
CN112924686B (zh) * 2019-12-05 2024-08-23 复旦大学 用于检测血清淀粉样蛋白a的免疫层析试纸条及其制备与检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027216A1 (en) 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
AU2003263660A1 (en) 2003-08-29 2005-03-16 Pantarhei Bioscience B.V. Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood
WO2005078124A2 (de) 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs

Also Published As

Publication number Publication date
ATE500513T1 (de) 2011-03-15
PL2053407T3 (pl) 2011-07-29
SI2053407T1 (sl) 2011-06-30
PT2053407E (pt) 2011-05-10
DK2053407T3 (da) 2011-06-20
EP2053407A1 (en) 2009-04-29
EP2053407B1 (en) 2011-03-02
ES2362051T3 (es) 2011-06-27
HRP20110371T1 (hr) 2011-06-30
DE602008005228D1 (de) 2011-04-14
CY1112415T1 (el) 2015-12-09

Similar Documents

Publication Publication Date Title
Wilkinson et al. Type 1 Diabeti c Children and Siblings Share a Decrease in Dendritic Cell and Monocyt e Numbers but are Differentiated by Expansion of CD4+ T Cells Expressing IL-17
EP4235181A3 (en) Biomarker detection process and assay of neurological condition
EP4335932A3 (en) Methods of monitoring conditions by sequence analysis
WO2005123779A3 (en) Antibodies binding to cd34+/cd36+ fetal but not to adult cells
ATE456055T1 (de) Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden
IN2014MN02060A (el)
EP3355059A3 (en) Biomarker assay of neurological condition
NZ601590A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
EP2634573A3 (en) A cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
WO2011005893A3 (en) Biomarkers and methods for detecting alzheimer's disease
HK1206423A1 (en) Oligomeric a in the diagnosis, prognosis, and monitoring of alzheimer's disease
EP2863220A3 (en) Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics
WO2009143519A3 (en) Biomarkers for myocardial ischemia
CA2820841C (en) Competitive biosensor having elevated sensitivity
WO2012006056A3 (en) Ccr6 as a biomarker of alzheimer's disease
WO2011109112A3 (en) Method of detecting tau protein and tau fragments in serum
WO2010144553A3 (en) Methods for diagnosing blood vessel reocclusion
WO2007140971A3 (en) Cell adhesion proteins as biomarker for alzheimer's disease
WO2010009440A3 (en) Non-invasive fetal rhd genotyping from maternal whole blood
WO2010000467A8 (en) Asc as a marker for lung cancer
BR112014007947A2 (pt) método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5
DE602006013453D1 (de) Verfahren zur anreicherung fötaler zellen
BR112013030646A2 (pt) uso diagnóstico de pró-somatostatina
PT2053407E (pt) Componente da prote?na amil?ide p s?rica (sap, samp) como marcador de progn?stico e diagn?stico para o diagn?stico pr?-natal de trissomia 21 (s?ndrome de down)

Legal Events

Date Code Title Description
PG Patent granted
ML Lapse due to non-payment of fees

Effective date: 20120503